Journal for ImmunoTherapy of Cancer (Nov 2023)
1153 BCG022: a HER3×MET bispecific antibody-drug conjugate (BsADC) targeting key mechanisms of bypass resistance in multiple tumor types
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)